Showing results (21-30 of 492) with videos related to
Sort By:
Pageof 50
Hematology. American Society of Hematology. Education Program|January 18, 2011
Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiologyOla LandgrenSeminars in Oncology|January 8, 2017
Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk statusOla LandgrenHematology. American Society of Hematology. Education Program|December 10, 2021
Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic eventsOla LandgrenBMJ (Clinical Research Ed.)|September 22, 2020
Emerging immunotherapies in multiple myelomaUrvi A Shah, Sham MailankodyBest Practice & Research. Clinical Haematology|March 7, 2020
CAR T and CAR NK cells in multiple myeloma: Expanding the targetsUrvi A Shah, Sham MailankodySeminars in Oncology|January 8, 2017
Controversies in multiple myeloma: Evidence-based updateInhye E Ahn, Sham MailankodyObesity (Silver Spring, Md.)|June 12, 2017
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor DiseaseJonathan N Hofmann, Sham Mailankody, Neha Korde, et al.Hematology. American Society of Hematology. Education Program|December 9, 2023
Current use of CAR T cells to treat multiple myelomaRoss S Firestone, Sham MailankodyScientific Reports|October 18, 2019
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomidePhoebe A Huang, Shaunna L Beedie, Cindy H Chau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma PatientsS Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.Pageof 50